A dual recombinant strategy to quantify PreS1 antibody in hepatitis B patients with genotype B or C virus by ELISA

Yumin Li, Xiaoyu Wen, Jing Zhan, Tingting Cao, Xiumei Chi, Huanyi Cheng, Qingrui Huang, Wenyi Zhang, Junqi Niu, Huan Du, Zhenning Liu · 2026

Read A dual recombinant strategy to quantify PreS1 antibody in hepatitis B patients with genotype B or C virus by ELISA by Yumin Li, Xiaoyu Wen, Jing Zhan, Tingting Cao, Xiumei Chi, Huanyi Cheng, Qingrui Huang, Wenyi Zhang, Junqi Niu, Huan Du, Zhenning Liu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13682388.txt.

Description

Yumin Li and ten colleagues build a better blood test for antibodies against hepatitis B virus. The antibodies target preS1, a viral part the virus needs to enter liver cells. Higher antibody levels go with faster clearance of the virus. But test accuracy suffers because the virus comes in many genotypes.

Their assay focuses on genotypes B and C, which cover most patients in China. They fused preS1 parts from both types into one protein. They also made a mouse-human chimeric antibody to serve as the measuring standard. The finished ELISA kit proved specific, accurate, and stable. Its range spans ten to one hundred nanograms per milliliter.

Catalog record

CREATORYumin Li, Xiaoyu Wen, Jing Zhan, Tingting Cao, Xiumei Chi, Huanyi Cheng, Qingrui Huang, Wenyi Zhang, Junqi Niu, Huan Du, Zhenning Liu
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE54 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13682388

Browse the full library · About the Tower of Babel